Edward L. Goodman
- Pharmacology top 10%
- Applied Microbiology and Biotechnology top 2%
- Epidemiology
- Clinical Biochemistry top 5%
- Infectious Diseases
- Co-authors
- Timothy J. SullivanWilliam R. LumryBarbara J. StarkHarry S. EarlGary N. GrossAlan R. HullRandall K. HolmesAndrew C. Faust
- Topics
- Antibiotic Use and Resistance (2 papers)Antibiotics Pharmacokinetics and Efficacy (2 papers)Antibiotic Resistance in Bacteria (2 papers)
- Journals
- Clinical Infectious DiseasesJournal of Allergy and Clinical ImmunologyAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesMexico
In The Last Decade
Edward L. Goodman
9 papers receiving 335 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 136
- Applied Microbiology and Biotechnology 113
- Epidemiology 107
- Clinical Biochemistry 76
- Infectious Diseases 74
Countries citing papers authored by Edward L. Goodman
This map shows the geographic impact of Edward L. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward L. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward L. Goodman more than expected).
Fields of papers citing papers by Edward L. Goodman
This network shows the impact of papers produced by Edward L. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward L. Goodman. The network helps show where Edward L. Goodman may publish in the future.
Co-authorship network of co-authors of Edward L. Goodman
This figure shows the co-authorship network connecting the top 25 collaborators of Edward L. Goodman. A scholar is included among the top collaborators of Edward L. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward L. Goodman. Edward L. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 89 | |
| 3 | 4 | |
| 4 | 61 | |
| 5 | 22 | |
| 6 | Preventing central venous catheter-related complications. A roundtable discussion | 8 |
| 7 | 83 | |
| 8 | 4 | |
| 9 | 31 | |
| 10 | 56 |
About Edward L. Goodman
Edward L. Goodman is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Otorhinolaryngology, having authored 10 papers that have together received 358 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (113 citations), Clinical Biochemistry (76 citations) and Pharmacology (136 citations). Edward L. Goodman has collaborated with scholars based in United States and Mexico. Frequent co-authors include Timothy J. Sullivan, William R. Lumry, Barbara J. Stark, Harry S. Earl, Gary N. Gross, Alan R. Hull, Randall K. Holmes, Andrew C. Faust, James van Gelder and Jay P. Sanford. Their work appears in journals such as Clinical Infectious Diseases, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.